Alterity Therapeutics (ATHE) Total Current Liabilities (2009 - 2025)

Alterity Therapeutics' Total Current Liabilities history runs 17 years deep, the most recent figure standing at $1.7 million for Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 4.49% year-over-year to $1.7 million in Q4 2025; TTM through Dec 2025 was $1.7 million, a 4.49% decrease from a year earlier, with the FY2025 full-year figure at $2.3 million, down 36.08% from the prior year.
• Total Current Liabilities slipped to $1.7 million in Q4 2025 per ATHE's latest filing, from $2.3 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $4.2 million in Q2 2022 and bottomed at -$5.1 million in Q2 2024.
• The 5-year median for Total Current Liabilities is $2.3 million (2025), against an average of $1.6 million.
• Across the five-year window, Total Current Liabilities sank 11742.89% in 2024 and jumped 144.37% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $2.7 million in 2021, then grew by 25.41% to $3.4 million in 2022, then slipped by 14.91% to $2.9 million in 2023, then plunged by 39.23% to $1.8 million in 2024, then fell by 4.49% to $1.7 million in 2025.
• Per Business Quant, the three latest ATHE Total Current Liabilities figures stand at $1.7 million (Q4 2025), $2.3 million (Q2 2025), and $1.8 million (Q4 2024).